Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INFUNASDAQ:LUNGNASDAQ:PDEXOTCMKTS:UEEC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINFUInfuSystem$6.38+2.7%$5.42$4.61▼$9.97$134.08M1.8199,029 shs132,300 shsLUNGPulmonx$2.98-1.7%$3.89$2.83▼$9.37$119.97M0.52310,711 shs161,296 shsPDEXPro-Dex$40.57+2.6%$50.03$16.84▼$70.26$129.01M0.1732,060 shs17,220 shsUEECUnited Health Products$0.13+1.8%$0.22$0.05▼$0.28$33.25M-1.36130,930 shs308,840 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINFUInfuSystem+2.74%+7.23%+3.74%+10.00%-10.64%LUNGPulmonx-1.65%-12.35%-13.12%-62.61%-48.35%PDEXPro-Dex+2.55%-1.65%-5.91%-18.50%+109.99%UEECUnited Health Products+1.80%-13.18%-45.05%-35.10%-20.22%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINFUInfuSystem2.7837 of 5 stars2.03.00.00.02.44.21.9LUNGPulmonx3.696 of 5 stars3.35.00.00.02.13.31.3PDEXPro-Dex3.2463 of 5 stars3.52.00.00.02.22.51.9UEECUnited Health Products0.7522 of 5 stars0.05.00.00.02.80.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINFUInfuSystem 4.00Strong Buy$13.00103.76% UpsideLUNGPulmonx 2.63Moderate Buy$11.53286.74% UpsidePDEXPro-Dex 3.00Buy$56.0038.03% UpsideUEECUnited Health Products 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest UEEC, INFU, PDEX, and LUNG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2025PDEXPro-DexAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$54.00 ➝ $56.005/22/2025LUNGPulmonxCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.50 ➝ $4.155/8/2025INFUInfuSystemB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/1/2025LUNGPulmonxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $15.005/1/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$10.00 ➝ $9.005/1/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$17.00 ➝ $17.003/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINFUInfuSystem$137.58M0.97$0.50 per share12.79$2.47 per share2.58LUNGPulmonx$87.47M1.37N/AN/A$3.09 per share0.96PDEXPro-Dex$64.12M2.06$1.17 per share34.81$9.76 per share4.16UEECUnited Health Products$40K831.23N/AN/A($0.01) per share-12.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINFUInfuSystem$870K$0.14106.3520.58N/A1.12%2.78%1.41%N/ALUNGPulmonx-$60.84M-$1.44N/AN/AN/A-67.31%-55.36%-33.53%7/30/2025 (Estimated)PDEXPro-Dex$2.13M$2.8020.1819.69N/A11.06%21.68%12.40%9/4/2025 (Estimated)UEECUnited Health Products-$2.62M-$0.02N/A∞N/AN/AN/A-840.17%N/ALatest UEEC, INFU, PDEX, and LUNG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025LUNGPulmonx-$0.37-$0.36+$0.01-$0.36$22.03 million$22.54 million5/1/2025Q3 2025PDEXPro-Dex$0.47$0.98+$0.51$0.98$17.70 million$17.41 million3/28/2025Q4 2024UEECUnited Health ProductsN/A-$0.01N/A-$0.01N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINFUInfuSystemN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/AUEECUnited Health ProductsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINFUInfuSystem0.501.981.59LUNGPulmonx0.407.706.77PDEXPro-Dex0.332.581.44UEECUnited Health ProductsN/A0.030.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINFUInfuSystem71.13%LUNGPulmonx91.04%PDEXPro-Dex15.28%UEECUnited Health Products0.07%Insider OwnershipCompanyInsider OwnershipINFUInfuSystem11.40%LUNGPulmonx6.80%PDEXPro-Dex47.50%UEECUnited Health Products1.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINFUInfuSystem41021.02 million19.10 millionOptionableLUNGPulmonx25040.26 million37.24 millionOptionablePDEXPro-Dex1403.26 million1.71 millionNot OptionableUEECUnited Health Products4256.16 million246.33 millionNot OptionableUEEC, INFU, PDEX, and LUNG HeadlinesRecent News About These CompaniesShort Interest in United Health Products, Inc. (OTCMKTS:UEEC) Declines By 75.0%June 14 at 2:53 AM | americanbankingnews.comUnited Health Products (OTCMKTS:UEEC) Shares Down 6.4% - Here's What HappenedJune 11, 2025 | americanbankingnews.comUnited Health Products Provides Regulatory Application UpdateJune 6, 2025 | finance.yahoo.comUnited Health Products, Inc. (OTCMKTS:UEEC) Short Interest Down 89.6% in MayMay 30, 2025 | marketbeat.comUnited Health Products (OTCMKTS:UEEC) Shares Down 4.7% - Here's What HappenedMay 22, 2025 | marketbeat.comUnited Health Products Announces OTCQB Uplisting and FDA UpdateMay 1, 2025 | finance.yahoo.comUnited Health Products Provides Update on FDA and OTC Markets ApplicationsMarch 28, 2025 | finance.yahoo.comUnited Health Products Provides Update on Capital Markets and Regulatory ProcessesMarch 14, 2025 | finance.yahoo.comUnited Health Products Provides Update on Clinical Study ProcessDecember 2, 2024 | globenewswire.com2 recalls impacting Lubbock area supermarkets, including H-E-B, Walmart, UnitedOctober 31, 2024 | yahoo.comUnited Laboratories’ Antibiotic Product Gains Key ApprovalOctober 26, 2024 | msn.comEco Bandage, Greener Living Products receive ECRM Health Care Buyers’ Choice AwardsOctober 14, 2024 | drugstorenews.comUnited overhauls economy-class wine menu with 4 new optionsOctober 1, 2024 | thepointsguy.comUnited Supermarkets Partners on New Health Care BenefitSeptember 30, 2024 | progressivegrocer.comRising Extreme Heat Compounds the U.S. Maternal Health CrisisSeptember 30, 2024 | americanprogress.orgUnited Healthcare cuts UF Health from in-provider networkSeptember 5, 2024 | mainstreetdailynews.comUnited Therapeutics: Strong Buy Rating on FDA Exclusivity and Market Dominance for Tyvaso DPIAugust 20, 2024 | markets.businessinsider.comUnited Health Products Submits Response Letter to FDAAugust 19, 2024 | globenewswire.comFDA warns producer about lead levels in its apple cinnamon puree productsAugust 17, 2024 | msn.comUnitedHealthcare: Health care coverage and benefitsAugust 14, 2024 | unitedhealthgroup.comHealth Headlines: How to spot ultra-processed foodsAugust 13, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsToyota Supercharges Joby: $250M Capital Infusion Ignites Stock By Jeffrey Neal Johnson | May 28, 2025View Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock UEEC, INFU, PDEX, and LUNG Company DescriptionsInfuSystem NYSE:INFU$6.38 +0.17 (+2.74%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$6.37 -0.01 (-0.14%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Pulmonx NASDAQ:LUNG$2.98 -0.05 (-1.65%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$3.05 +0.07 (+2.48%) As of 06/16/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.Pro-Dex NASDAQ:PDEX$40.57 +1.01 (+2.55%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$40.48 -0.09 (-0.21%) As of 06/16/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.United Health Products OTCMKTS:UEEC$0.13 +0.00 (+1.80%) As of 06/16/2025 03:55 PM EasternUnited Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
